FDA Inspection 1168103 — Chemo Biosynthesis s.r.l.

Chemo Biosynthesis s.r.l. — FEI 3002806806

The FDA completed an inspection of Chemo Biosynthesis s.r.l. on November 26, 2021 in Corana. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 26, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Corana (Italy)

Additional Details

Mutual Recognition Agreement (MRA)